Cerity Partners
BSX icon

Cerity Partners’s Boston Scientific BSX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$140M Buy
1,301,504
+10,625
+0.8% +$1.14M 0.25% 88
2025
Q1
$130M Buy
1,290,879
+653,370
+102% +$65.9M 0.26% 78
2024
Q4
$55.9M Sell
637,509
-74,373
-10% -$6.52M 0.12% 155
2024
Q3
$59.7M Buy
711,882
+80,334
+13% +$6.73M 0.13% 156
2024
Q2
$48.6M Sell
631,548
-31,219
-5% -$2.4M 0.13% 155
2024
Q1
$45.4M Buy
662,767
+111,346
+20% +$7.63M 0.12% 172
2023
Q4
$31.9M Buy
551,421
+145,359
+36% +$8.4M 0.1% 179
2023
Q3
$21.4M Sell
406,062
-75,018
-16% -$3.96M 0.1% 178
2023
Q2
$26M Buy
481,080
+6,732
+1% +$364K 0.1% 191
2023
Q1
$25.6M Buy
474,348
+25,967
+6% +$1.4M 0.06% 208
2022
Q4
$20.7M Buy
448,381
+32,904
+8% +$1.52M 0.13% 161
2022
Q3
$16.1M Buy
415,477
+815
+0.2% +$31.6K 0.19% 105
2022
Q2
$15.5M Buy
414,662
+324,804
+361% +$12.1M 0.17% 121
2022
Q1
$3.98M Sell
89,858
-3,141
-3% -$139K 0.06% 223
2021
Q4
$3.95M Buy
92,999
+8,511
+10% +$361K 0.06% 229
2021
Q3
$3.67M Sell
84,488
-3,282
-4% -$142K 0.08% 186
2021
Q2
$3.75M Sell
87,770
-40,731
-32% -$1.74M 0.08% 184
2021
Q1
$4.97M Sell
128,501
-17,598
-12% -$680K 0.12% 149
2020
Q4
$5.25M Buy
146,099
+10,121
+7% +$364K 0.17% 120
2020
Q3
$5.2M Buy
135,978
+90,010
+196% +$3.44M 0.21% 92
2020
Q2
$1.61M Buy
45,968
+3,041
+7% +$107K 0.09% 150
2020
Q1
$1.4M Buy
42,927
+11,458
+36% +$374K 0.09% 159
2019
Q4
$1.42M Sell
31,469
-66,130
-68% -$2.99M 0.07% 200
2019
Q3
$3.97M Buy
97,599
+39,233
+67% +$1.6M 0.23% 97
2019
Q2
$2.51M Sell
58,366
-19,157
-25% -$824K 0.16% 133
2019
Q1
$2.98M Sell
77,523
-48,217
-38% -$1.85M 0.2% 109
2018
Q4
$4.44M Buy
125,740
+6,642
+6% +$235K 0.3% 75
2018
Q3
$4.59M Sell
119,098
-5,505
-4% -$212K 0.32% 78
2018
Q2
$4.08M Sell
124,603
-6,951
-5% -$227K 0.3% 84
2018
Q1
$3.59M Sell
131,554
-7,702
-6% -$210K 0.27% 93
2017
Q4
$3.45M Buy
139,256
+7,270
+6% +$180K 0.23% 99
2017
Q3
$3.85M Buy
131,986
+39,022
+42% +$1.14M 0.27% 88
2017
Q2
$3.94M Sell
92,964
-16,338
-15% -$692K 0.33% 67
2017
Q1
$2.72M Buy
+109,302
New +$2.72M 0.23% 89